Sandbox Financial Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,156
Closed -$213K 98
2022
Q4
$213K Buy
+4,156
New +$199K 0.15% 74
2022
Q3
Sell
-4,602
Closed -$241K 90
2022
Q2
$241K Sell
4,602
-511
-10% -$26K 0.17% 70
2022
Q1
$265K Buy
5,113
+928
+22% +$48.1K 0.15% 75
2021
Q4
$247K Buy
+4,185
New +$207K 0.16% 78

Other funds holding PFE

Sandbox Financial Partners's PFE Position: Q1 2023 in Review

Sandbox Financial Partners sold out of Pfizer (PFE) in Q1 2023, closing a stake of 4,156 shares — an estimated $213K sold.

Sandbox Financial Partners first reported a position in PFE in Q4 2021 and held it in 4 quarters. The position peaked at $265K in Q1 2022. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Sandbox Financial Partners reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Sandbox Financial Partners sold 4,156 Pfizer shares in Q1 2023, an estimated $213K.
  • Sandbox Financial Partners first reported a position in Pfizer in Q4 2021 and held it in 4 quarters.
  • Sandbox Financial Partners's Pfizer position peaked at $265K in Q1 2022.
  • 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Sandbox Financial Partners's 13F filing for Q1 2023, filed 21 Apr 2023.